AS
Ablative Solutions, Inc.
SEC filingOther Health Care · Wakefield, MA
Amount raised$10.4Msold at filing
Total offering$45M$34.6M still open
Investors in the raise10count reported to the SEC
FiledNov 26, 2025first sale Nov 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ronald D. BacheExecutive Officer, Director
Louis D. CannonDirector
John D. KerschenDirector
Geoff D. PardoDirector
Brian D. RaulsExecutive Officer
Benjamin D. TsaiDirector
Executive officers, directors and promoters as listed on the Form D.